North America:
The neurostimulation devices market in North America is well-established, driven by a high prevalence of neurological disorders, increasing adoption of advanced medical technologies, and a robust healthcare infrastructure. The United States and Canada are the key markets in this region, benefiting from a growing aging population, rising incidence of chronic pain, epilepsy,...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian